Introduction
Studies with tissue culture cell lines have demonstrated a critical role for c-myc protein in cell dierentiation and growth (reviewed in Marcu et al., 1992; Spencer and Groudine, 1991) . Regulated c-myc expression is apparently essential for determining whether a cell will dierentiate. For example, c-myc mRNA is downregulated when erythroid cell lines are induced to dierentiate following exposure to dimethylsulphoxide. However, if the cells constitutively express c-myc from a transgene that is not down-regulated, the cells fail to dierentiate (Coppola and Cole, 1986) . Conversely, blocking c-myc expression prevents entry into S-phase and promotes terminal dierentiation (reviewed in Packham and Cleveland, 1995) . c-myc expression is also controlled during cell growth transitions, being upregulated 50-fold or more as quiescent cells enter the cell cycle (Blanchard et al., 1985) . Two additional observations support an active, causal role for c-myc protein as a regulator of cell dierentiation and replication. (i) Constitutive expression of c-myc can force cells to enter S-phase or to undergo apoptosis under conditions of serum starvation (Evan et al., 1992) . (ii) Abnormal c-myc regulation resulting from gene ampli®cation, proviral insertion, or chromosomal translocation induces tumors in animals (Marcu et al., 1992) .
Animal model systems are being exploited to investigate what c-myc does and how its expression is regulated in nontransformed cells. c-myc expression is crucial for embryonic development in rodents, because homozygous c-myc knockout transgenic mice die in utero (Davis et al., 1993) . It is also one of the`early response' genes that is up-regulated when quiescent adult hepatocytes are induced to replicate following partial hepatectomy (surgical excision of 70% of the liver mass). c-myc mRNA is barely detectable in adult liver but is up-regulated and easily detectable within 2 h post-hepatectomy Morello et al., 1990a,b; Sobczak et al., 1989) . The induction of c-myc and related growth-regulating genes is presumably essential for total liver regeneration (reviewed in Fausto and Webber, 1994; .
Our interest in c-myc expression in liver stems from three observations linking the mRNA coding region with post-transcriptional regulation. (i) c-myc mRNA is regulated post-transcriptionally during fetal liver development (Morello et al., 1989; Gruppuso et al., 1993) . (ii) It is also stabilized fourfold by 6 h posthepatectomy . (iii) c-myc upregulation during liver regeneration depends only on sequences within the coding region, because c-myc transgenes driven by a constitutive promoter and lacking the 3'-and 5'-untranslated regions (UTR's) are regulated in parallel with the endogenous c-myc gene (Lavenu et al., 1995; Morello et al., 1990a Morello et al., ,b, 1993 Sobczak et al., 1989) . In other words, transgenederived mRNA containing only the c-myc coding region is undetectable in resting adult liver but is induced within 1 h following partial hepatectomy.
A major question raised by these studies is how the coding region aects c-myc mRNA half-life. Some insights have come from transfection studies with cmyc genes lacking either the 3'-UTR or parts of the coding region. Two distinct c-myc half-life determinants were identi®ed. One is an AU-rich sequence in the 3'-UTR; the other is an approximately 180 nucleotide (nt), purine-rich sequence located at approximately nts 1705 ± 1886 in the coding region and encoding 60 amino acids at the protein carboxy terminus (Bernstein et al., 1992; Bonnieu et al., 1990; Herrick and Ross, 1994; Jones and Cole, 1987; Lachman et al., 1986; Wisdom and Lee, 1990, 1991; Yeilding et al., 1996) . We refer to this region as the Coding Region mRNA stability Determinant or CRD. To investigate how the CRD in¯uences mRNA stability, we have exploited an in vitro mRNA decay assay in which polyribosomes from an erythroleukemia cell line are incubated for varying times and the halflife of endogenous c-myc mRNA is determined (Ross and Kobs, 1986) . This cell-free system re¯ects many aspects of intracellular mRNA decay (reviewed in Ross, 1995) . Two observations suggested that the CRD is a site for binding of a speci®c protein, the Coding Region Determinant-Binding Protein (CRD-BP) which, when bound to the CRD, protects the CRD from attack by an endonuclease. First, when synthetic competitor CRD RNA was added to the reactions, cmyc mRNA was speci®cally destabilized eightfold (Bernstein et al., 1992) . In the presence of the competitor, but not in its absence, a decay product resulting from endonucleolytic attack within the CRD was observed. Second, the CRD-BP, a cytoplasmic protein that binds to the c-myc CRD, was identi®ed and puri®ed (Bernstein et al., 1992; Prokipcak et al., 1994) . Our interpretation of these observations is that the CRD-BP is normally bound to the CRD in c-myc mRNA and protects the mRNA from cleavage by a ribosome-associated endonuclease. Without competitor CRD RNA, the mRNA is still relatively unstable in vitro but is protected from endonucleolytic attack because the CRD-BP shields the CRD. mRNA to which the CRD-BP is bound is degraded by a previously characterized 3' to 5' decay pathway (Brewer and Ross, 1988) . In the presence of competitor CRD RNA, the CRD-BP is titrated from the mRNA, which deprotects the CRD, allows the CRD to be attacked by the endonuclease, and accounts for the observed destabilization of the mRNA.
In the present work, we sought to establish a connection between these in vitro experiments and in vivo studies implicating the coding region in posttranscriptional regulation of c-myc mRNA in hepatocytes. Speci®cally, we have asked whether c-myc mRNA levels correlate with changes in the abundance or binding anity of the CRD-BP in fetal liver, resting adult liver, and regenerating adult liver. We show that fetal and neonatal rat liver express both c-myc mRNA and CRD-BP; adult resting hepatocytes contain little or no c-myc mRNA or CRD-BP; adult regenerating hepatocytes express c-myc mRNA but not CRD-BP. Therefore, the CRD-BP is developmentally regulated and might in¯uence c-myc expression in dierentiating cells of the fetus and neonate. CRD-BP is not required for cell replication, at least in some adult cells. Expression of the CRD-BP in fetal hepatocytes and transformed tissue culture cell lines from adults also suggests it might be an oncofetal protein.
Results
Correlation of CRD-BP and c-myc mRNA expression in fetal, neonatal, and resting adult liver Previous in vitro studies suggested a link between the CRD-BP and c-myc mRNA stability (Bernstein et al., 1992; Herrick and Ross, 1994) . To assess this link further using an animal model, we have asked whether c-myc mRNA abundance correlates with CRD-BP expression in rat liver. c-myc mRNA was easily detected by Northern analysis in 19 day old fetal rat liver but was at least 50-fold less abundant in adult liver (Figure 1 ). mRNA depletion during the fetal to adult transition cannot be explained by a developmental switch in the ratio of non-parenchymal to parenchymal cells, because freshly isolated fetal and adult hepatocytes themselves exhibited the same dierence in mRNA levels as whole liver samples (Figure 1) . We conclude that c-myc mRNA is expressed abundantly in fetal but not adult hepatocytes.
To determine whether CRD-BP adundance correlates with c-myc mRNA levels, the expression of active CRD-BP was monitored by a gel-shift assay (RNAprotein binding) in which a CRD [ 32 P]RNA probe was incubated with a high salt polyribosome extract called ribosomal salt wash (RSW). RSW was used because it contains most of the CRD-BP in the cell (Bernstein et al., 1992; Prokipcak et al., 1994) . The CRD [ 32 P]RNA probe corresponded to the last 182 nts of the c-myc coding region (CRD RNA), and ribonucleoprotein (RNP) complexes were separated from free RNA by electrophoresis in a non-denaturing gel. A RNP complex was detected in RSW from fetal free polysomes but not adult polysomes (Figure 2) , indicating a correlation between c-myc mRNA levels and CRD-BP expression. c-myc expression is regulated post-transcriptionally in liver cells, since the c-myc genë is transcribed actively in both fetal and adult hepatocytes (Morello et al., 1989; Gruppuso et al., 1993) . Therefore, the correlation between c-myc mRNA and CRD-BP abundance in fetal and adult hepatocytes is consistent with a role for CRD-BP in stabilizing fetal c-myc mRNA.
Characterization of fetal rat liver CRD-BP and evidence that it corresponds to human CRD-BP
A combination of u.v. crosslinking, Western blotting and antibody supershift experiments con®rmed that fetal rat liver contains a protein related to human CRD-BP. First, the fetal liver RNP complex migrated close to the complex formed with CRD-BP from K562 (human) cells (Figure 2 , compare lanes 2 and 6). Second, proteins in human and rat RSW's were u.v. crosslinked by incubating each RSW with uniformly labeled CRD [ 32 P]RNA, exposing the samples to u.v. light to generate crosslinked RNP's, treating with RNase A to remove all but a small fragment of crosslinked RNA, and analysing covalent RNP complexes by SDS ± PAGE. Fetal rat liver RSW generated a single band that comigrated with CRD-BP from K562 cells ( Figure 3a , lanes 2 and 3). This band was also observed with RSW from three human hepatoma cell lines, HepG2, HuH7 and Hep3B (lanes 5 ± 7), and the presence of active CRD-BP in these lines was con®rmed by gel-shift analysis (data not shown). No such band was observed with adult liver, and no other bands were detected in the human or fetal rat RSW samples. A reconstruction experiment was then performed as a control to ask whether CRD-BP is present in adult liver but degraded during RSW preparation. Three RSW samples were prepared: one from adult rat liver; another from 7 day old neonatal liver, which contains abundant CRD-BP; the third from a 1 : 1 weight mixture of adult and neonatal liver.
Each RSW was then analysed by gel-shift with CRD [ 32 P]RNA. CRD-BP abundance in the mixture fell midway between that of the adult and neonatal liver alone (data not shown). Therefore, CRD-BP is not selectively degraded while preparing adult liver RSW (see also Figure 4 ).
To compare the RNA-binding speci®city of fetal rat and human CRD-BP's, fetal liver and K562 cell RSW's were incubated in separate reactions with [ ; lanes 4 ± 6) with 1 mg of RSW from K562 cells (lanes 2 and 5) or 17 day fetal rat liver (lanes 3 and 6). Lanes 1 and 4: no protein added to the reactions. Arrow: the CRD/CRD-BP complex slightly faster than the human complex in the nondenaturing gel (Figure 3b , compare lanes 2 and 3). We have not investigated the basis for this dierence.
Western blotting was then performed to con®rm the presence of CRD-BP in fetal liver, to determine whether adult liver cytosol contains any CRD-BP and to ask whether CRD-BP is expressed abundantly in other adult tissues. Using IgY from chickens immunized with highly puri®ed human CRD-BP, a single *70 kDa band (p70) was detected with K562 cell RSW (Figure 4a, lane 1) , and a doublet in the 70 kDa region was detected with fetal liver RSW (lane 2). The IgY also cross-reacted with an 85 kDa protein (p85) of unknown origin. Little or no CRD-BP was observed in adult liver cytosol (lane 8). This result cannot be explained by indiscriminate protein degradation during sample preparation, because the control antigen (hsp90) from adult liver reacted strongly with anti-hsp90 antibody (Figure 4b, lane 8) . Therefore, adult rat liver contains little or no CRD-BP, as was the case with the other adult organs tested (Figure 4a , lanes 3 ± 12). Again, failure to detect a strong CRD-BP signal in adult tissue extracts cannot be explained by indiscriminate protein degradation during sample preparation, because intact hsp90 was detected in all adult tissues (Figure 4b) , and p85 was detected in many adult tissues. The faint bands detected in the p70 region in some adult tissues (e.g., lung and stomach) are unlikely to be CRD-BP, because they are smaller than 70 kDa.
Four additional observations con®rmed the specificity of the antibody used in Figure 4 and the relationship between human and fetal rat liver 70 kDa CRD-BP's. (i) There exists a complete correlation between p70 detection by Western blot and gel-shift analysis; i.e., only those extracts from cells generating a gel-shift band also contain a p70 band by Western blotting (Figures 2 ± 4) . (ii) p70 from K562 cell extracts co-migrated with highly puri®ed human CRD-BP (Figure 5a , compare lanes 1 and 2; Prokipcak et al., 1994) . (iii) The p70 band was absent from Western blots probed with IgY from non-immunized chickens (Figure 5a, lanes 3 and 4) . (iv) Addition of anti-CRD-BP IgY in a gel-shift assay produced a super-shifted complex (Figure 5b, compare lanes 4 and 5) . Although the quantity of super-shifted RNP was small, the result was reproducible, and the size of the supershifted band Prokipcak et al., 1994) and K562 cytosolic extract (40 mg; lanes 2 and 4) were fractionated in a 10% SDS-polyacrylamide gel. Western analysis was performed using immune IgY (lanes 1 and 2) or pre-immune IgY (lanes 3 and 4) as the primary antibody. (b) supershift. Uniformly labeled CRD [ 32 P]RNA was incubated with 3 mg of RSW from K562 cells (lanes 2 ± 5). Heparin, which is usually added to a ®nal concentration of 2.5 mg/ml (lanes 1 and 2), was not added to the reactions shown in lanes 3 ± 5, in order to increase assay sensitivity (see Materials and methods). Pre-immune IgY and anti-CRD-BP IgY were added to lanes 4 and 5, respectively. The samples were electrophoresed in a non-denaturing gel, and RNP complexes were visualized by autoradiography. The large arrow indicates the CRD/CRD-BP complex (p70), which is present in all lanes containing RSW. The arrow labeled p170 indicates the position of a second complex that is detectable only when heparin is omitted from the binding reactions
Developmental regulation of CRD-BP P Leeds et al was consistent with antibody binding to the CRD-BP/ CRD complex. Moreover, we can account for a low percentage supershift, because anti-CRD-BP IgY was generated using denatured CRD-BP, which would have reduced anity for the non-denatured CRD-BP analysed in Figure 5b . The slower-migrating complex (p170, lanes 3 ± 5) was generated because heparin was omitted from the gel-shift assay (Materials and methods). By u.v. crosslinking analysis, the p170 band contains a *170 kDa protein that has not been further characterized (data not shown). In summary, the data of Figures 3 ± 5 con®rm the speci®city of the anti-CRD-BP antibody, the presence of CRD-BP in fetal liver, and its absence from the cytoplasm of many adult tissues.
Ontogeny of CRD-BP expression
c-myc mRNA is relatively abundant in fetal liver, persists for approximately 1 week of postnatal life, and then disappears (Gruppuso et al., 1996) . The CRD-BP is also relatively abundant on fetal day 19, declines over the next several days, persists and accumulates during the ®rst week of neonatal life, and begins to decline by post-natal week 2 ( Figure 6 ). Therefore, liver CRD-BP activity roughly parallels c-myc mRNA during the fetal and neonatal periods.
Lack of induction of CRD-BP during liver regeneration following partial hepatectomy
The results of Figures 1 ± 6 support two alternative models of CRD-BP regulation. (i) CRD-BP functions primarily during cell dierentiation and development, because it is abundant in less dierentiated fetal and neonatal hepatocytes but poorly expressed in fully dierentiated adult hepatocytes (and other adult organs).
(ii) CRD-BP is expressed only in dividing cells and is not observed in adult liver because adult hepatocytes are quiescent, while fetal and neonatal hepatocytes are capable of proliferation. To investigate these models, we analysed CRD-BP expression in regenerating liver, a process during which differentiated adult hepatocytes proliferate. Within 2 h after partial hepatectomy, c-myc mRNA abundance increases 10-to 50-fold in the liver Sobczak et al., 1989) , and at least part of this increase occurs via post-transcriptional mechanisms (Morello et al., 1990a (Morello et al., ,b, 1993 Sobczak et al., 1989; . In contrast, little or no CRD-BP was detected between 30 min and 30 h after partial hepatectomy, either by gel-shift with RSW (Figure 7a ) or by Western blotting with total cytoplasmic extracts (Figure 7b ). Failure to observe a gel shift was not the result of RNA degradation during polysome preparation, because standard polysome preparation procedures were used, and rRNA was intact, as determined by agarose gel electrophoresis (data not shown). Failure to detect CRD-BP by Westerns did not result from indiscriminate protein degradation in the extracts, because intact hsp90 was detected at all time points (Figure 7c ). The absence of CRD-BP at 30 h is particularly signi®cant, since 30 h is a time of active hepatocyte replication. These results suggest a role for CRD-BP in developing or dierentiating cells.
Discussion
The CRD-BP was discovered while analysing c-myc mRNA decay in vitro using polysomes from a human erythroleukemia cell line (Bernstein et al., 1992) . Data from those studies suggested a possible function for this protein, namely, to bind to the c-myc CRD and shield the CRD from attack by an endonuclease. When the CRD-BP was induced to dissociate from the mRNA, the CRD would become exposed to the endonuclease. Therefore, CRD-BP dissociation would encourage ecient degradation of the mRNA, permitting cells to deplete themselves of translatable c-myc mRNA very rapidly. This model could account for the rapid uctuations in c-myc mRNA abundance observed during cell dierentiation. While this mechanism for CRD-BP action has not been con®rmed, it is strengthened by studies demonstrating that the CRD aects c-myc mRNA metabolism in intact cells Lavenu et al., 1995; Morello et al., 1993; Wisdom and Lee, 1991; Yeilding et al., 1996) .
The experiments described here further tested CRD-BP function in vivo by comparing its expression with that of c-myc mRNA in rodent liver. Ribosomal salt wash (RSW) from fetal rat liver polyribosomes contains a protein that, like human CRD-BP, is *70 kDa and binds to human CRD RNA. The human and fetal liver p70's are the only such RSW proteins capable of forming a heparin-insensitive, crosslinkable complex with CRD RNA (Figure 3a) . Moreover, antibodies against human CRD-BP recognize one or two fetal rat liver proteins that migrate at or close to 70 kDa (Figure 4a ). For these reasons, we conclude that fetal rat liver p70 is the homologue of human CRD-BP. According to our model of CRD-BP function, the CRD-BP in fetal liver should stabilize cmyc mRNA, which is consistent with studies demonstrating c-myc up-regulation by post-transcriptional mechanisms in fetal liver Morello et al., 1989) .
Our studies generated three additional ®ndings. (i) Neither the CRD-BP nor c-myc mRNA is detected in adult liver. (ii) CRD-BP and c-myc mRNA are detected in hepatocytes 7 to 14 days postnatally, but both then disappear during the transition from neonate to adult. (iii) Although c-myc mRNA is up-regulated posttranscriptionally following partial hepatectomy in the adult, CRD-BP remains undetectable during the regeneration process, even while the hepatocytes are replicating.
The simplest interpretation of these data is that the CRD-BP is a fetal or oncofetal protein whose expression correlates with cell development/differentiation but not cell replication. To our knowledge, it is the ®rst mammalian mRNA-binding protein expressed abundantly only in a fetal/neonatal tissue and not in adult tissues. The CRD-BP is not a marker of cell proliferation, because it is absent from adult hepatocytes at 30 h post-hepatectomy, when the cells are dividing. The designation of CRD-BP as a fetal protein is reinforced by two additional observations. (i) Proliferating adult hepatocytes do not resemble fetal cells, either morphologically or functionally . Rather, they maintain their specialized functions, are not considered dedifferentiated, and do not accumulate known fetal markers such as a-fetoprotein or CRD-BP. (ii) CRD-BP is not detected in cytosol from many adult tissues (Figure 4) , although it might be expressed in rare progenitor cells, a possibility which can be tested using in situ techniques.
The failure of CRD-BP to be up-regulated posthepatectomy raises the question of how c-myc is controlled post-transcriptionally. Why is the mRNA so unstable in resting hepatocytes? How is it stabilized following partial hepatectomy if regenerating hepatocytes lack the CRD-BP? One possibility is that a related but dierent protein serves the same function in adult cells as CRD-BP in fetal cells. We consider this notion unlikely, because such a protein should have been detected in adult liver using the gel-shift assay (Figure 7a ). Another possibility is that the endonuclease responsible for cleaving the unprotected (protein-free) CRD is highly active in resting hepatocytes and eciently repressed during liver regeneration. There is precedent for RNA abundance being regulated as a function of RNase levels. For example, the activities of the interferoninducible RNase L (Krause et al., 1985) , a hepatocyte endoribonuclease from Xenopus (Dompenciel et al., 1995; Pastori et al., 1991) , and RNase 4 (Tiany et al., 1996) are regulated in response to viral infection, hormones, and cell dierentiation. Perhaps c-myc mRNA up-regulation after hepatectomy correlates with endonuclease down-regulation. In preliminary experiments, a magnesium-dependent endonuclease capable of cleaving the CRD of a deproteinized RNA substrate has been detected in adult rat liver RSW (data not shown). Regulation of c-myc mRNA by controlling the activity of an mRNase would add to the growing list of posttranscriptional mechanisms exploited by cells to modulate c-myc abundance.
Materials and methods

Partial hepatectomies
Male Sprague-Dawley rats (Harlan Sprague-Dawley, Inc., Indianapolis, IN) weighing 250 ± 275 g were maintained on a 12 h light-dark cycle and fed standard laboratory chow. Seventy percent partial hepatectomies were performed under ether anaesthesia (Higgins and Anderson, 1931) . Animals were sacri®ced at dierent times post-hepatectomy, and the liver remnant was obtained and divided into two aliquots. One was used to prepare cytosolic extract for Western blotting. The other was used to prepare polyribosomes.
Hepatocyte isolation and Northern blotting
All procedures were performed at 2 ± 48C, unless otherwise noted. Single cell suspensions of fetal rat hepatocytes were prepared as previously described (Curran et al., 1993) . Adult rat hepatocytes were isolated by a two-step collagenase procedure (Braun et al., 1988) . Total RNA was prepared from isolated hepatocytes or frozen liver tissue by homogenization in guanidinium thiocyanate followed by centrifugation over a cesium chloride cushion . Following electrophoresis through agarose-formaldehyde gels, Northern blot analysis of c-myc was performed as described previously (Braun et al., 1988; Webber et al., 1994 ) using a rat c-myc exon 3 probe from a 711 bp BglII-PstI DNA fragment from plasmid pMomyc.
Isolation of polyribosomes and preparation of ribosomal salt wash
For experiments requiring fetal and neonatal rat liver ribosomal salt wash (RSW), free and bound polyribosomes were prepared at 48C using a modi®cation of previously described methods (Ramsey and Steele, 1976; Takiguchi et al., 1985) . Freshly isolated liver (2 ± 3 g) was washed at 48C with buer A (50 mM HEPES (pH 7.4), 5 mM MgCl 2 , 3 mM dithiothreitol (DTT), 0.25 M sucrose) and homogenized in buer B (buer A plus 0.75 mM KCl and 200 units/ml RNasin (Promega)) at 3 ml/g using ten strokes of a motor-driven te¯on pestle at 1750 r.p.m. Following lowspeed centrifugation (740 g, 2 min), the supernatant was centrifuged at 40 000 g for 40 min. The supernatant, which contains free polyribosomes, was saved on ice. The pellet, which contains membrane-bound polyribosomes, was resuspended in 6 ml of cell sap (Ramsey and Steele, 1976) . One ninth volume of 10% Triton X-100 was added and after a 10 min incubation on ice, the homogenate was centrifuged at 1200 g for 5 min to sediment nuclei. Membrane-bound polyribosomes were then solubilized by adding one ninth volume of sodium deoxycholate to the supernatant. Supernatants containing free and membranebound polyribosomes (5 ml) were layered over discontinuous sucrose gradients consisting of 4 ml of buer C (buer A plus 2 M sucrose, 250 mM KCl, 100 units/ml RNasin) beneath 4 ml of buer D (1.5 ml buer B plus 2 ml of 2 M sucrose plus 1 ml cell sap) in 13.2 ml polyallomer tubes. Following centrifugation at 103 000 g for 16 h at 28C in a Beckman SW41Ti rotor, the polysomal pellet was washed twice in buer E (10 mM Tris-Cl (pH 7.4), 1 mM KOAc, 1.5 mM Mg(OAc) 2 , 2 mM DTT) and resuspended in 200 ± 400 ml of buer E. Polyribosomes and RSW from regenerating rat livers, hepatoma cell lines, and K562 cells were prepared as previously described (Ross and Kobs, 1986) . Protein concentration was measured using the BioRad assay (BioRad).
u.v. crosslinking, gel-shift and gel-supershift assays
Uniformly labeled RNA's corresponding to the CRD or nts 1 ± 164 of b-globin mRNA were synthesized in SP6 transcription reactions containing [a- 32 P]UTP (Prokipcak et al., 1994) . u.v. crosslinking analysis was performed as previously described (Prokipcak et al., 1994) . For standard gel-shifts, RSW protein from the various sources was diluted with buer F (buer E plus 1.0 M NaCl) to equal protein concentrations. Diluted RSW (3 ml) was incubated for 10 min at 308C with 1 ng of uniformly labeled RNA in a 20 ml reaction containing 10 mM Tris-Cl (pH 7.5), 2.5 mM EDTA, 2 mM DTT, 5% glycerol, 0.5 mg/ml E. coli RNA and 1.0 mg/ml bovine serum albumin. Ribonuclease T1 (Sigma) was added to a concentration of 25 units/ml and the reaction was incubated an additional 10 min at 308C. Heparin was added to a concentration of 2.5 mg/ml and the reaction was incubated again at 308C for 10 min and then electrophoresed in a 6% nondenaturing acrylamide gel (60 : 1 acrylamide : bis-acrylamide) at 70 volts for 90 min.
Supershift assays were modi®ed in two ways. First, heparin was omitted, in order to increase assay sensitivity. Second, the RSW was incubated with [ 32 P]RNA at 308C for 7 min, then 3 mg of either pre-immune IgY or anti-CRD-BP IgY were added, and the incubation was continued for 7 min. It was necessary to increase assay sensitivity, because anti-CRD-BP IgY was generated with denatured immunogen (see below), while the supershifted band contained native CRD-BP.
Protein isolation and Western blotting
Cytoplasmic lysates from exponentially growing K562 cells were prepared by concentrating cells using low speed centrifugation and resuspending them at 50 ml per 3610 6 cells in buer G (10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl 2 , 0.5% Nonidet P-40, 100 mg/ml phenylmethylsulphonyl¯uoride (PMSF), and 2 mg/ml each of aprotinin, leupeptin and pepstatin A). Following a 10 min incubation on ice, cells were vortexed for 5 s, and the lysate was centrifuged at 17 000 g for 30 s.
To isolate cytoplasmic protein from rat liver and other organs, the tissue (*0.3 cm 3 ) was minced, washed in ice cold phosphate buered saline, and placed in 1.0 ml buer H (10 mM Tris-HCl (pH 7.4), 10 mM KCl, 1.5 mM MgCl 2 , 2 mM PMSF, 0.2 mM EGTA and 2 mg/ml each of aprotinin, leupeptin, and pepstatin A) on ice. Cells were lysed by ten strokes of a motor driven te¯on pestle. The lysate was then centrifuged at 17 000 g for 5 min, and the supernatant was harvested.
Anti-CRD-BP antibodies were generated by immunizing one female chicken with a total of 40 mg of denatured CRD-BP puri®ed to homogeneity as previously described (Prokipcak et al., 1994) . Preimmune and immune chicken IgY were puri®ed by sequential polyethelene glycol precipitations (Gassmann et al., 1990) . Cellular proteins were electrophoresed in 10% polyacrylamide-SDS gels and transferred to nitrocellulose membranes (Schleicher and Schuell, Keene, NH) using standard methods (Harlow and Lane, 1988) . The blots were probed and developed as previously described (Zelus et al., 1996) using either a 1 : 2000 dilution of primary antibody (chicken anti-CRD-BP IgY) and a 1 : 3000 dilution of secondary antibody (antichicken IgY HRP conjugate (Promega)) or a 1 : 1000 dilution of primary antibody (rabbit anti-hsp90 IgG) and a 1 : 8000 dilution of secondary antibody (anti-goat IgG HRP conjugate (Sigma)).
